Bayer Healthdare Pharmaceuticals Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Bayer Healthdare Pharmaceuticals Inc.

Sort by

Viewing results 1‒25 of 192

Merck & Co Inc
Merck to open £1bn London research centre with plea for government support of industry
...He said chancellor Jeremy Hunt and the health department should address conflicts with the pharmaceutical industry over drug prices and hurdles to running clinical trials in the NHS....
October 15, 2023
Drug prices
US drugmakers withdraw from NHS pricing agreement as costs soar
...AbbVie and Eli Lilly have withdrawn from the deal after the German conglomerate Bayer’s pharmaceutical chief executive told the Financial Times on Monday that it was reducing its UK footprint and cutting...
January 16, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Legal services
Meet the FT top 20 in-house legal leaders
...Gabriel Harnier group general counsel, BAYER Three years ago, under Harnier’s leadership, the legal team at Bayer, the German pharmaceuticals and life sciences company, moved its contracting, data privacy...
October 12, 2022
LexZoetis Inc
Zoetis/Elanco: pandemic pet boom brings out the animal spirits Premium content
...But it has been bulking up through a series of acquisitions, most recently buying Bayer’s animal-health unit in 2019. The stock is up 15 per cent this year....
November 5, 2021
Coronavirus
US hospitals panic-buy drugs ahead of coronavirus influx
...Bayer, the German pharmaceutical group, also said it would donate 3m of its malaria tablets, but as they are not approved in the US, they need an emergency authorisation from the FDA....
March 21, 2020
BlackRock Inc
BlackRock rebukes Siemens on its environmental record
...In April last year, BlackRock refused to back the board of German pharmaceutical group Bayer at the company’s annual meeting, in a largely symbolic protest over its handling of a merger with pesticides-maker...
February 6, 2020
FT Live
Investing in America
Foreign companies as drivers of US growth, resilience and competitiveness
Tuesday, 10 DecemberHybrid Conference
Mergers & Acquisitions
JPMorgan Chase set to scoop record fee for Allergan sale
...The pharmaceutical and healthcare sectors have been among the most active with $479bn worth of transactions announced....
August 13, 2019
News in-depthThe Big Read
J&J: The next target of anger over America’s opioid crisis?
...“They want to make sure it’s a sleepy, boring bond-like equity, not something that will turn into Bayer with Monsanto,” he says, referring to the German chemical company’s legal battles over whether its...
September 5, 2019
News in-depthThe Big Read
The Apple effect: Germany fears being left behind by Big Tech
...software company valued at $2.5bn, says he has spent a lot of time trying to figure out why Germany has lost the spirit of the Gründerzeit — the “founding epoch” in the late 19th century when Daimler, Bayer...
January 29, 2020
FT News Briefing podcast9 min listen
Trade war escalates, Uber falls, $2bn Bayer verdict
...trade war with China hands US stocks their biggest one-day drop in months, Uber shares lose more than a tenth of their value in the ride-hailing app’s second day of trading and a California court orders Bayer...
May 14, 2019
GSK PLC
GlaxoSmithKline to break up after striking Pfizer joint venture
...That puts it ahead of its nearest competitors Johnson & Johnson, Sanofi and Bayer, which hold about 4 per cent market shares each....
December 19, 2018
News in-depthNikkei Asia
Club Med’s Chinese owner Fosun bets billions on family fun Premium content
...A version of this article was first published by the Nikkei Asian Review on July 5, 2019. ©201 Nikkei Inc. All rights reserved....
July 16, 2019
News in-depthCapital markets
Bond investors fail to blink as megadeals fan leverage
...A sale of $15bn of debt by Bayer on Monday to fund the acquisition was inundated with orders, allowing the German pharmaceutical and chemicals group to offer investors a lower yield than initially planned...
June 20, 2018
Pharmaceuticals sector
Amazon halts healthcare rally on Wall Street
...Those concerns sent healthdare stocks down more than 2 per cent on Tuesday, knocking them out of the top spot in the year-to-date S&P 500 sector ranking and into second place behind consumer discretionary...
January 31, 2018
News in-depthUS & Canadian companies
GSK’s move for Pfizer’s consumer arm divides market
...Company insiders were quick to emphasise that Ms Walmsley has set out a clear framework for capital allocation: her priority is boosting performance in pharmaceuticals, followed by protecting the dividend...
March 22, 2018
FT Live
Funding Biopharma Innovation
Strategies for investing in drug development and commercialization
Wednesday, 26 June345 Park Avenue South, New York, NY, USA
LexUS & Canadian companies
Pfizer: shelf medication Premium content
...In 2014, Bayer paid seven times sales to German peer Merck in a $14bn deal....
October 10, 2017
US & Canadian companies
Pfizer weighs sale of consumer health business
...Nestlé, the Swiss foods group, has said that it is in the market for such assets, while analysts also cite drugmakers such as GlaxoSmithKline, Bayer, Sanofi and Johnson & Johnson as potential buyers....
October 10, 2017
Due Diligence
Private equity’s tax dilemma Premium content
...watchdogs, Makan Delrahim from the US justice department and EU competition boss Margrethe Vestager, are set to meet in Brussels: A couple of big deals under their jurisdictions are still pending, including Bayer-Monsanto...
February 20, 2018
InterviewHow to Lead
Paul Polman: how I fended off a hostile takeover bid
...Chaired by Marijn Dekkers, former CEO of Germany’s Bayer pharmaceutical group, the board dismissed the offer as too low and making no strategic sense....
December 3, 2017
News in-depthUS & Canadian companies
Hunt for earnings growth reshapes chemicals sector
...Hemmed in between gargantuan suppliers of natural resources — often oil and gas groups — on one side, and large customers in sectors such as automotive, consumer goods and pharmaceuticals on the other, chemicals...
May 30, 2017
News in-depthRetail & Consumer industry
Corporate moments to look out for in 2017
...Martin Arnold in London The Snap IPO Technology investors’ eyes will be firmly on whether Snap Inc can snap, crackle and pop on its stock market debut, expected as early as March 2017....
December 30, 2016
News in-depthThe Big Read
Drug prices: Tweaking the formula
...But Alexander Moscho, UK head of Bayer, the German drugmaker, says the qualy system is not flexible enough for the new world of personalised medicines....
April 25, 2016
US & Canadian companies
Medivation agrees to $10bn takeover talks
...The former Pfizer and Bayer executive has made dealmaking a key pillar of his strategy to strengthen the pharmaceutical company since taking over last year....
July 5, 2016
US & Canadian companies
Sanofi threatens to go hostile in $9.3bn pursuit of Medivation
...The battle for Medivation marks the second big deal attempted by Mr Brandicourt since the veteran of Pfizer and Bayer took charge of Sanofi a year ago....
May 5, 2016
LexPharmaceuticals sector
Animal health: double or quits
...Possible buyers include Zoetis and pharma groups that still have animal health divisions: Lilly, Bayer and possibly Boehringer Ingelheim, which is privately held....
November 13, 2015

Previous pagePage 1 of 8Next page